PHE Screening has published an updated information pack to help GPs and primary care professionals advise well men aged 50 and over about prostate specific antigen (PSA) testing for prostate cancer.
We, the sickle cell and thalassaemia (SCT) screening programme, are launching an exciting new project which aims to engage the public and service users. This will help improve how we deliver screening for sickle cell and thalassaemia.
Diabetes UK estimates that more than 4 million people are living with diabetes in the UK. That number has been increasing by around 5% a year, which underlines the scale of the challenge facing local diabetic eye screening programmes that …
We at the sickle cell and thalassemia screening programme laboratory support service receive many interesting questions from our service users. These often fall into themes so we thought it would be useful to share some of this information with the …
During March we are mailing out copies of the new print run of the Screening tests for you and your baby booklet to every NHS trust in England that has a maternity unit.
We use key performance indicators (KPIs) to measure and drive improvements in the NHS screening programmes.
NHS Screening Programmes offers screening to all eligible patients within a defined population. However, ensuring equality of access to services for patient groups with specific needs can be challenging.
If you’ve contacted the screening helpdesk recently, you may have noticed, and you may have even completed, our user survey.
The nurse specialist is an important role in the NHS Abdominal Aortic Aneurysm Screening Programme.
It’s been a year since the NHS newborn blood spot screening programme expanded screening for an additional 4 inherited metabolic diseases (IMDs): maple syrup urine disease (MSUD) isovaleric acidaemia (IVA) glutaric aciduria type 1 (GA1) homocystinuria (pyridoxine unresponsive) (HCU) We …